{"id":6568,"date":"2021-03-04T08:20:41","date_gmt":"2021-03-04T07:20:41","guid":{"rendered":"http:\/\/www.seventure.fr\/?p=6568"},"modified":"2021-03-04T08:20:41","modified_gmt":"2021-03-04T07:20:41","slug":"ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of","status":"publish","type":"post","link":"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/","title":{"rendered":"YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders,  as well as the Inclusion of the Obese Patients in the Second Arm of the Trial"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[101,2],"tags":[],"class_list":["post-6568","post","type-post","status-publish","format-standard","hentry","category-life-sciences-en","category-seventure-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders, as well as the Inclusion of the Obese Patients in the Second Arm of the Trial | Seventure<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Annick Aubert\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/\",\"url\":\"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/\",\"name\":\"YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders, as well as the Inclusion of the Obese Patients in the Second Arm of the Trial | Seventure\",\"isPartOf\":{\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\"},\"datePublished\":\"2021-03-04T07:20:41+00:00\",\"author\":{\"@id\":\"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/44ea53a59fb31bf4b0785993c3b80072\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.seventure.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders, as well as the Inclusion of the Obese Patients in the Second Arm of the Trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.seventure.fr\/en\/#website\",\"url\":\"https:\/\/www.seventure.fr\/en\/\",\"name\":\"Seventure\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.seventure.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/44ea53a59fb31bf4b0785993c3b80072\",\"name\":\"Annick Aubert\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/edc623b312ecb7962458df6a11a541ef3877f93b9972ca70b7d45cd5e8e5f9c7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/edc623b312ecb7962458df6a11a541ef3877f93b9972ca70b7d45cd5e8e5f9c7?s=96&d=mm&r=g\",\"caption\":\"Annick Aubert\"},\"url\":\"https:\/\/www.seventure.fr\/en\/author\/annick-aubert\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders, as well as the Inclusion of the Obese Patients in the Second Arm of the Trial | Seventure","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/","twitter_misc":{"Written by":"Annick Aubert"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/","url":"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/","name":"YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders, as well as the Inclusion of the Obese Patients in the Second Arm of the Trial | Seventure","isPartOf":{"@id":"https:\/\/www.seventure.fr\/en\/#website"},"datePublished":"2021-03-04T07:20:41+00:00","author":{"@id":"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/44ea53a59fb31bf4b0785993c3b80072"},"breadcrumb":{"@id":"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.seventure.fr\/en\/ysopia-bioscience-announces-the-first-positive-safety-results-of-its-causality-study-in-obesity-and-associated-metabolic-disorders-as-well-as-the-inclusion-of-the-obese-patients-in-the-second-arm-of\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.seventure.fr\/en\/"},{"@type":"ListItem","position":2,"name":"YSOPIA Bioscience Announces the First Positive Safety Results of its CAUSALITY Study in Obesity and Associated Metabolic Disorders, as well as the Inclusion of the Obese Patients in the Second Arm of the Trial"}]},{"@type":"WebSite","@id":"https:\/\/www.seventure.fr\/en\/#website","url":"https:\/\/www.seventure.fr\/en\/","name":"Seventure","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.seventure.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/44ea53a59fb31bf4b0785993c3b80072","name":"Annick Aubert","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.seventure.fr\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/edc623b312ecb7962458df6a11a541ef3877f93b9972ca70b7d45cd5e8e5f9c7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/edc623b312ecb7962458df6a11a541ef3877f93b9972ca70b7d45cd5e8e5f9c7?s=96&d=mm&r=g","caption":"Annick Aubert"},"url":"https:\/\/www.seventure.fr\/en\/author\/annick-aubert\/"}]}},"_links":{"self":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/6568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/comments?post=6568"}],"version-history":[{"count":3,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/6568\/revisions"}],"predecessor-version":[{"id":6573,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/posts\/6568\/revisions\/6573"}],"wp:attachment":[{"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/media?parent=6568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/categories?post=6568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.seventure.fr\/en\/wp-json\/wp\/v2\/tags?post=6568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}